Patent infringement: Roche loses US appeal in Sandoz lung disease drug case Ruchika Sharma24 Dec 2022 6:00 AM GMTSan Francisco-based Genentech's Esbriet is used to treat IPF, a serious chronic lung disease. Roche earned over $1 billion last year from worldwide...
Alembic Pharma bags USFDA nod for idiopathic pulmonary fibrosis drug Pirfenidone Ruchika Sharma24 May 2022 11:44 AM GMTPirfenidone Tablets are indicated for the treatment of idiopathic pulmonary fibrosis (IPF).
Roche highly anticipated cancer immunotherapy fails in first late-stage trial Ruchika Sharma3 April 2022 4:00 AM GMTTiragolumab works by selectively binding itself to TIGIT, a receptor found on immune system cells that normally serves to prevent an immune attack...
Roche loses bid to block Sandoz generic lung-disease drug Ruchika Sharma26 March 2022 3:30 AM GMTAndrews ruled for Sandoz on Tuesday and found Sandoz's label only encouraged non-infringing uses of the drug.
Novartis moves court against Roche seeking Rs 1565 crore overpaid amount in patent licensing pact Medical Dialogues Team1 July 2021 11:53 AM GMTNew Delhi: Accusing Roche of illegally pocketing fee from a 16-year-old patent licensing contract, Novartis has filed a lawsuit in U.S. District Court...
HC allows DCGI to process Reliance's package insert of cancer Pooja Bhatia Bhatia20 Nov 2015 4:15 AM GMTNew Delhi : Delhi High Court today told the Drug Controller General of India (DCGI) that it can process the application of Reliance Life Sciences for...
